Aquestive Therapeutics In...

AI Score

0

Unlock

3.04
-0.07 (-2.25%)
At close: Jan 14, 2025, 3:59 PM
3.06
0.49%
After-hours Jan 14, 2025, 04:07 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -7.87M -54.41M -70.54M -55.78M -66.25M -61.38M -8.94M -9.60M
Depreciation & Amortization 1.34M 2.39M 2.96M 3.44M 2.90M 3.24M 3.80M 3.89M
Stock-Based Compensation 2.69M 4.38M 6.82M 6.58M 7.07M 29.94M n/a n/a
Other Working Capital -259.00K 24.77M 3.56M -828.00K 1.60M -1.49M 1.38M 152.00K
Other Non-Cash Items 2.80M 5.85M 15.69M 4.71M 2.29M 1.93M 3.08M 3.83M
Deferred Income Tax n/a n/a 13.82M n/a 4.90M 5.28M n/a n/a
Change in Working Capital -5.34M 32.01M -1.73M -4.41M -11.12M 8.00M 7.88M -6.29M
Operating Cash Flow -6.38M -9.79M -32.98M -45.46M -60.21M -12.99M 5.82M -8.18M
Capital Expenditures -995.00K -2.52M -913.00K -517.00K -663.00K -1.82M -2.07M -976.00K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a 1.17M
Other Investing Acitivies n/a -1.50M n/a n/a n/a n/a n/a 1.17M
Investing Cash Flow -995.00K -2.52M -913.00K -517.00K -663.00K -1.82M -2.07M 190.00K
Debt Repayment -20.39M n/a n/a -22.50M 17.06M n/a 5.00M 6.94M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 15.45M -2.02M 329.00K 44.74M -6.77M -10.79M -586.00K -1.25M
Financial Cash Flow 3.97M 11.56M 30.11M 28.46M 49.60M 58.03M 4.41M 5.69M
Net Cash Flow -3.40M -751.00K -3.78M -17.52M -11.27M 43.22M 8.17M -2.30M
Free Cash Flow -7.38M -12.31M -33.89M -45.98M -60.87M -14.81M 3.76M -9.15M